HomeEMCURE • NSE
add
Emcure Pharmaceuticals Ltd
Nakaraang pagsara
₹1,374.20
Sakop ng araw
₹1,360.35 - ₹1,386.00
Sakop ng taon
₹1,225.00 - ₹1,580.00
Market cap
248.29B INR
Average na Volume
122.31K
P/E ratio
45.54
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 20.02B | 20.38% |
Gastos sa pagpapatakbo | 9.29B | 17.93% |
Net na kita | 1.95B | 39.82% |
Net profit margin | 9.72 | 16.13% |
Kita sa bawat share | 10.33 | — |
EBITDA | 3.79B | 19.19% |
Aktuwal na % ng binabayarang buwis | 26.28% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.32B | -57.14% |
Kabuuang asset | 81.24B | 20.99% |
Kabuuang sagutin | 38.21B | 0.54% |
Kabuuang equity | 43.03B | — |
Natitirang share | 188.36M | — |
Presyo para makapag-book | 6.28 | — |
Return on assets | — | — |
Return on capital | 12.97% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.95B | 39.82% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Itinatag
Abr 16, 1981
Website
Mga Empleyado
11,146
